Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1994 Apr;38(4):889–893. doi: 10.1128/aac.38.4.889

In vitro activity of biapenem (L-627), a new carbapenem, against anaerobes.

K E Aldridge 1, N Morice 1, D D Schiro 1
PMCID: PMC284564  PMID: 8031067

Abstract

We tested 441 clinical strains of anaerobes by using a broth microdilution method to determine the in vitro activity of biapenem for comparison with those of other agents. Biapenem had activity comparable to those of imipenem and meropenem against all groups of anaerobes with MICs for 90% of the strains tested of 0.06 to 2 micrograms/ml. Against the Bacteroides fragilis group, biapenem was more active than ampicillin-sulbactam, ticarcillin-clavulanate, piperacillin, cefoxitin, cefotaxime, and ceftriaxone. Biapenem was also active against all of the B. capillosus, Prevotella, Clostridium, and Eubacterium strains and anaerobic cocci tested. Against all of the anaerobes tested, biapenem was 32- and 4-fold more active than clindamycin and metronidazole, respectively. These data indicate broad-spectrum activity by biapenem against anaerobes.

Full text

PDF
890

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appelbaum P. C., Spangler S. K., Jacobs M. R. Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam. J Antimicrob Chemother. 1993 Aug;32(2):223–231. doi: 10.1093/jac/32.2.223. [DOI] [PubMed] [Google Scholar]
  2. Catchpole C. R., Wise R., Thornber D., Andrews J. M. In vitro activity of L-627, a new carbapenem. Antimicrob Agents Chemother. 1992 Sep;36(9):1928–1934. doi: 10.1128/aac.36.9.1928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cuchural G. J., Jr, Malamy M. H., Tally F. P. Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob Agents Chemother. 1986 Nov;30(5):645–648. doi: 10.1128/aac.30.5.645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cuchural G. J., Jr, Tally F. P., Storey J. R., Malamy M. H. Transfer of beta-lactamase-associated cefoxitin resistance in Bacteroides fragilis. Antimicrob Agents Chemother. 1986 May;29(5):918–920. doi: 10.1128/aac.29.5.918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hikida M., Kawashima K., Yoshida M., Mitsuhashi S. Inactivation of new carbapenem antibiotics by dehydropeptidase-I from porcine and human renal cortex. J Antimicrob Chemother. 1992 Aug;30(2):129–134. doi: 10.1093/jac/30.2.129. [DOI] [PubMed] [Google Scholar]
  6. Kahan F. M., Kropp H., Sundelof J. G., Birnbaum J. Thienamycin: development of imipenen-cilastatin. J Antimicrob Chemother. 1983 Dec;12 (Suppl 500):1–35. doi: 10.1093/jac/12.suppl_d.1. [DOI] [PubMed] [Google Scholar]
  7. Kropp H., Sundelof J. G., Hajdu R., Kahan F. M. Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase. Antimicrob Agents Chemother. 1982 Jul;22(1):62–70. doi: 10.1128/aac.22.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Malanoski G. J., Collins L., Wennersten C., Moellering R. C., Jr, Eliopoulos G. M. In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria. Antimicrob Agents Chemother. 1993 Sep;37(9):2009–2016. doi: 10.1128/aac.37.9.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Nord C. E., Lindmark A., Persson I. In vitro activity of L-627 against anaerobic bacteria. Eur J Clin Microbiol Infect Dis. 1992 Aug;11(8):757–760. doi: 10.1007/BF01989987. [DOI] [PubMed] [Google Scholar]
  10. Olsson-Liljequist B., Dornbusch K., Nord C. E. Characterization of three different beta-lactamases from the Bacteroides fragilis group. Antimicrob Agents Chemother. 1980 Aug;18(2):220–225. doi: 10.1128/aac.18.2.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sader H. S., Jones R. N. Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs. Eur J Clin Microbiol Infect Dis. 1993 May;12(5):384–391. doi: 10.1007/BF01964439. [DOI] [PubMed] [Google Scholar]
  12. Sato K., Matsuura Y., Inoue M., Mitsuhashi S. Properties of a new penicillinase type produced by Bacteroides fragilis. Antimicrob Agents Chemother. 1982 Oct;22(4):579–584. doi: 10.1128/aac.22.4.579. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES